伤口愈合
细胞凋亡
小RNA
基因敲除
炎症
医学
化学
癌症研究
免疫学
基因
生物化学
作者
Jiayi Mao,Shutong Qian,Qiuyu Zhao,Binfan Zhao,Bolun Lu,Liucheng Zhang,Xiyuan Mao,Yuguang Zhang,Wenguo Cui,Xiaoming Sun
出处
期刊:Med
[Elsevier]
日期:2024-02-01
卷期号:5 (2): 148-168.e8
被引量:5
标识
DOI:10.1016/j.medj.2024.01.006
摘要
BackgroundAdipose tissue-derived stem cell-derived apoptotic bodies (ADSC-ABs) have shown great potential for immunomodulation and regeneration, particularly in diabetic wound therapy. However, their local application has been limited by unclear regulatory mechanisms, rapid clearance, and short tissue retention times.MethodsWe analyzed the key role molecules and regulatory pathways of ADSC-ABs in regulating inflammatory macrophages by mRNA sequencing and microRNA (miRNA) sequencing and then verified them by gene knockdown. To prevent rapid clearance, we employed microfluidics technology to prepare methacrylate-anhydride gelatin (GelMA) microspheres (GMS) for controlled release of ABs. Finally, we evaluated the effectiveness of ADSC-AB-laden GMSs (ABs@GMSs) in a diabetic rat wound model.FindingsOur results demonstrated that ADSC-ABs effectively balanced macrophage inflammatory polarization through the janus kinase (JAK)-signal transducer and activator of transcription (STAT) pathway, mediated by miR-20a-5p. Furthermore, we showed that AB@GMSs had good biocompatibility, significantly delayed local clearance of ABs, and ameliorated diabetic wound inflammation and promoted vascularization, thus facilitating its healing.ConclusionsOur study reveals the regulatory mechanism of ADSC-ABs in balancing macrophage inflammatory polarization and highlightsthe importance of delaying their local clearance by GMSs. These findings have important implications for the development of novel therapies for diabetic wound healing.FundingThis research was supported by the National Key Research and Development Program of China (2020YFA0908200), National Natural Science Foundation of China (82272263, 82002053, 32000937, and 82202467), Shanghai "Rising Stars of Medical Talents" Youth Development Program (22MC1940300), Shanghai Municipal Health Commission (20204Y0354), and Shanghai Science and Technology Development Funds (22YF1421400).
科研通智能强力驱动
Strongly Powered by AbleSci AI